Finepoint Capital LP
BOSTON, MA · CIK 1608126 · 13F filing filed 2026-08-13
SEC-registered investment adviser since 2014 · limited partnership
- Assets managed$5.0bn
- Staff23 · 13 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds2 (2 hedge) · $5.0bn gross assets
- Websitefinepointcapital.com
- Form ADV · 2026-03-24SEC adviser record
- Legal entityFINEPOINT CAPITAL LP (US)
- Kindhedge funds, futures
- Others nearbyBoston, MA
As an employer
- Offices in1 country
- Private fundshedge 2
US visa salary filings
- Filings FY20242
- Median salary offered$162,500
- Middle half$143,750 – $181,250
- Job titles1
| Job title | Filings | Median |
|---|---|---|
| Financial AnalystBoston, MA | 2 | $162,500 |
Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Finepoint Capital LP.
$461.0m
reported value
+10.5% vs Q1 2026
6positions
100.0%in top 10
0 new
1 added
1 reduced
0 sold out
vs Q1 2026
Options: 1 call positions ($592.1m notional), 2 put positions ($1.7bn notional) – listed below, not included above.
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| QXO INC QXO | $313.0m67.89% | Added +4.3m |
| RXO INC RXO | $147.8m32.05% | Reduced -4.7m |
| ALEANNA INC ANNAW | $147.0k0.03% | Unchanged |
| ALEANNA INC ANNA | $80.4k0.02% | Unchanged |
| MONEYHERO LIMITED MNYWW | $37.0k0.01% | Unchanged |
| CALIDI BIOTHERAPEUTICS INC COM | $1770.00% | Unchanged |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $1.3bn1.7m shares | Added |
| MICROSOFT CORP MSFT · Call | $592.1m1.6m shares | New |
| INVESCO QQQ TR QQQ · Put | $467.4m634.8k shares | Unchanged |